Your browser doesn't support javascript.
loading
Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT).
Saccà, Francesco; Barnett, Carolina; Vu, Tuan; Peric, Stojan; Phillips, Glenn A; Zhao, Sihui; Qi, Cynthia Z; Gelinas, Deborah; Chiroli, Silvia; Verschuuren, Jan J G M.
Afiliação
  • Saccà F; Federico II University of Naples, Naples, Italy.
  • Barnett C; Prosserman Centre for Neuromuscular Diseases, Toronto General Hospital/UHN, Toronto, ON, Canada.
  • Vu T; University of South Florida Morsani College of Medicine, Tampa, FL, USA.
  • Peric S; University of Belgrade-Faculty of Medicine, University Clinical Center of Serbia-Neurology Clinic, Belgrade, Serbia.
  • Phillips GA; argenx US, Inc., Boston, MA, USA. gphillips@argenx.com.
  • Zhao S; argenx US, Inc., Boston, MA, USA.
  • Qi CZ; argenx US, Inc., Boston, MA, USA.
  • Gelinas D; argenx US, Inc., Boston, MA, USA.
  • Chiroli S; argenx Switzerland SA, Geneva, Switzerland.
  • Verschuuren JJGM; University Medical Center, RC Leiden, Netherlands.
J Neurol ; 270(4): 2096-2105, 2023 Apr.
Article em En | MEDLINE | ID: mdl-36598575
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Miastenia Gravis Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans / Newborn Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Miastenia Gravis Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans / Newborn Idioma: En Ano de publicação: 2023 Tipo de documento: Article